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Macrophages are, along with T CD4+lymphocytes, the
major targets of HIV-1 infection and play a key role in
viral pathogenesis as a significant reservoir. Identification
of the cellular cofactors involved in the production of
infectious HIV-1 from macrophages is thus crucial. Never-
theless molecular mechanisms allowing the production of
infectious particles from macrophages are not entirely
deciphered. In this study, we investigated the role of the
cellular cofactor TIP47 in HIV-1 morphogenesis in pri-
mary macrophages. Our data show that TIP47 is essential
for HIV-1 infectivity and propagation. Mutations in HIV-
1 Gag or Envelope (Env) proteins, which abolish interac-
tion with TIP47, impair HIV-1 propagation and infectivity
preventing colocalization of Gag and Env, and thereby
inhibiting Env incorporation into virions. Whereas dis-
ruption of Gag-TIP47 interaction increases slightly Gag
particles production, impaired Env-TIP47 binding reduces
Gag particles release and, strikingly, induces their reten-
tion in the viral assembly compartments. Thus, as in T
lymphocytes, TIP47 is critical for the efficient release of
infectious HIV-1 particles from the assembly compart-
ment of primary macrophages, making TIP47 a new
potential therapeutic target for limiting HIV-1 infectivity
and spreading. This work is funded by ANRS, SIDAC-
TION, ANR-07-JCJC-0102 programs and is part of the
activities of the HIV-ACE research network (HEALTH-F3-
2008-201095) supported by a grant of the European
Commission, within the Priority 1 ''Health'' work pro-
gramme of the 7th Framework Programme of the EU.
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